Table 3 Clinicopathological features of breast cancers according to MGB1 expression
n | Positive | (%) | P | |
---|---|---|---|---|
Age distribution | 0.37 | |||
>median/≤median | 114/124 | 51/63 | 45/51 | |
Pathological stage | 0.37 | |||
0/I/II/III/IV | 11/45/103/60/8 | 4/25/54/24/3 | 36/56/52/40/38 | |
pT | 0.25 | |||
is/1/2/3/4 | 11/81/110/16/13 | 4/43/54/4/5 | 36/53/49/25/38 | |
pN | 0.08 | |||
0/1/2/3 | 103/67/28/30 | 52/35/7/15 | 50/52/25/50 | |
Histological grade | 0.83 | |||
Grade 1/2/3 | 38/126/74 | 19/58/37 | 50/46/50 | |
ER status | 0.01 | |||
Negative/positive | 62/176 | 21/93 | 34/53 | |
PR status | 0.05 | |||
Negative/positive | 110/128 | 45/69 | 41/54 | |
HER2 gene amplification | 0.43 | |||
Negative/positive | 189/49 | 88/26 | 47/53 | |
CK5 | 0.03 | |||
Negative/positive | 209/29 | 106/8 | 51/28 | |
p53 | 0.47 | |||
Negative/positive | 174/64 | 86/28 | 49/44 |